Honeywell International Inc. Common Stock Ex Distribution When Issued
Honeywell International Inc. Common Stock Ex Distribution When Issued (HONIV) Stock Competitors & Peer Comparison
See (HONIV) competitors and their performances in Stock Market.
Peer Comparison Table: Conglomerates Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| HONIV | $200.99 | -0.50% | 127.6B | N/A | N/A | N/A |
| HON | $223.48 | +0.16% | 142.1B | 32.20 | $6.94 | +2.02% |
| MMM | $142.52 | -0.36% | 75B | 23.79 | $5.99 | +2.08% |
| VMI | $384.03 | -2.04% | 7.5B | 22.89 | $16.78 | +0.74% |
| SEB | $5,515.00 | -0.71% | 5.3B | 10.72 | $514.34 | +0.16% |
| IEP | $7.55 | +1.34% | 4.8B | -14.52 | -$0.52 | +26.65% |
| MDU | $20.60 | -0.05% | 4.2B | 22.14 | $0.93 | +2.68% |
| GFF | $70.53 | +0.01% | 3.3B | 69.90 | $1.01 | +1.13% |
| BBU | $31.46 | -2.09% | 2.8B | -108.97 | -$0.29 | +0.79% |
| VRTV | $169.99 | +0.02% | 2.3B | 8.58 | $19.82 | +1.11% |
Stock Comparison
HONIV vs HON Comparison April 2026
HONIV plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HONIV stands at 127.6B. In comparison, HON has a market cap of 142.1B. Regarding current trading prices, HONIV is priced at $200.99, while HON trades at $223.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HONIV currently has a P/E ratio of N/A, whereas HON's P/E ratio is 32.20. In terms of profitability, HONIV's ROE is +0.36%, compared to HON's ROE of +0.31%. Regarding short-term risk, HONIV is less volatile compared to HON. This indicates potentially lower risk in terms of short-term price fluctuations for HONIV.Check HON's competition here
HONIV vs MMM Comparison April 2026
HONIV plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HONIV stands at 127.6B. In comparison, MMM has a market cap of 75B. Regarding current trading prices, HONIV is priced at $200.99, while MMM trades at $142.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HONIV currently has a P/E ratio of N/A, whereas MMM's P/E ratio is 23.79. In terms of profitability, HONIV's ROE is +0.36%, compared to MMM's ROE of +0.72%. Regarding short-term risk, HONIV is less volatile compared to MMM. This indicates potentially lower risk in terms of short-term price fluctuations for HONIV.Check MMM's competition here
HONIV vs VMI Comparison April 2026
HONIV plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HONIV stands at 127.6B. In comparison, VMI has a market cap of 7.5B. Regarding current trading prices, HONIV is priced at $200.99, while VMI trades at $384.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HONIV currently has a P/E ratio of N/A, whereas VMI's P/E ratio is 22.89. In terms of profitability, HONIV's ROE is +0.36%, compared to VMI's ROE of +0.20%. Regarding short-term risk, HONIV is less volatile compared to VMI. This indicates potentially lower risk in terms of short-term price fluctuations for HONIV.Check VMI's competition here
HONIV vs SEB Comparison April 2026
HONIV plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HONIV stands at 127.6B. In comparison, SEB has a market cap of 5.3B. Regarding current trading prices, HONIV is priced at $200.99, while SEB trades at $5,515.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HONIV currently has a P/E ratio of N/A, whereas SEB's P/E ratio is 10.72. In terms of profitability, HONIV's ROE is +0.36%, compared to SEB's ROE of +0.10%. Regarding short-term risk, HONIV is less volatile compared to SEB. This indicates potentially lower risk in terms of short-term price fluctuations for HONIV.Check SEB's competition here
HONIV vs IEP Comparison April 2026
HONIV plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HONIV stands at 127.6B. In comparison, IEP has a market cap of 4.8B. Regarding current trading prices, HONIV is priced at $200.99, while IEP trades at $7.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HONIV currently has a P/E ratio of N/A, whereas IEP's P/E ratio is -14.52. In terms of profitability, HONIV's ROE is +0.36%, compared to IEP's ROE of -0.11%. Regarding short-term risk, HONIV is less volatile compared to IEP. This indicates potentially lower risk in terms of short-term price fluctuations for HONIV.Check IEP's competition here
HONIV vs MDU Comparison April 2026
HONIV plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HONIV stands at 127.6B. In comparison, MDU has a market cap of 4.2B. Regarding current trading prices, HONIV is priced at $200.99, while MDU trades at $20.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HONIV currently has a P/E ratio of N/A, whereas MDU's P/E ratio is 22.14. In terms of profitability, HONIV's ROE is +0.36%, compared to MDU's ROE of +0.07%. Regarding short-term risk, HONIV is less volatile compared to MDU. This indicates potentially lower risk in terms of short-term price fluctuations for HONIV.Check MDU's competition here
HONIV vs GFF Comparison April 2026
HONIV plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HONIV stands at 127.6B. In comparison, GFF has a market cap of 3.3B. Regarding current trading prices, HONIV is priced at $200.99, while GFF trades at $70.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HONIV currently has a P/E ratio of N/A, whereas GFF's P/E ratio is 69.90. In terms of profitability, HONIV's ROE is +0.36%, compared to GFF's ROE of +0.39%. Regarding short-term risk, HONIV is less volatile compared to GFF. This indicates potentially lower risk in terms of short-term price fluctuations for HONIV.Check GFF's competition here
HONIV vs BBU Comparison April 2026
HONIV plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HONIV stands at 127.6B. In comparison, BBU has a market cap of 2.8B. Regarding current trading prices, HONIV is priced at $200.99, while BBU trades at $31.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HONIV currently has a P/E ratio of N/A, whereas BBU's P/E ratio is -108.97. In terms of profitability, HONIV's ROE is +0.36%, compared to BBU's ROE of -0.01%. Regarding short-term risk, HONIV is less volatile compared to BBU. This indicates potentially lower risk in terms of short-term price fluctuations for HONIV.Check BBU's competition here
HONIV vs VRTV Comparison April 2026
HONIV plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HONIV stands at 127.6B. In comparison, VRTV has a market cap of 2.3B. Regarding current trading prices, HONIV is priced at $200.99, while VRTV trades at $169.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HONIV currently has a P/E ratio of N/A, whereas VRTV's P/E ratio is 8.58. In terms of profitability, HONIV's ROE is +0.36%, compared to VRTV's ROE of +0.49%. Regarding short-term risk, HONIV is more volatile compared to VRTV. This indicates potentially higher risk in terms of short-term price fluctuations for HONIV.Check VRTV's competition here
HONIV vs CODI-PC Comparison April 2026
HONIV plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HONIV stands at 127.6B. In comparison, CODI-PC has a market cap of 1.5B. Regarding current trading prices, HONIV is priced at $200.99, while CODI-PC trades at $19.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HONIV currently has a P/E ratio of N/A, whereas CODI-PC's P/E ratio is 23.12. In terms of profitability, HONIV's ROE is +0.36%, compared to CODI-PC's ROE of -0.40%. Regarding short-term risk, HONIV is less volatile compared to CODI-PC. This indicates potentially lower risk in terms of short-term price fluctuations for HONIV.Check CODI-PC's competition here
HONIV vs FBYDW Comparison April 2026
HONIV plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HONIV stands at 127.6B. In comparison, FBYDW has a market cap of 1.4B. Regarding current trading prices, HONIV is priced at $200.99, while FBYDW trades at $1.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HONIV currently has a P/E ratio of N/A, whereas FBYDW's P/E ratio is N/A. In terms of profitability, HONIV's ROE is +0.36%, compared to FBYDW's ROE of -0.39%. Regarding short-term risk, HONIV is less volatile compared to FBYDW. This indicates potentially lower risk in terms of short-term price fluctuations for HONIV.Check FBYDW's competition here
HONIV vs IRS Comparison April 2026
HONIV plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HONIV stands at 127.6B. In comparison, IRS has a market cap of 1.2B. Regarding current trading prices, HONIV is priced at $200.99, while IRS trades at $15.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HONIV currently has a P/E ratio of N/A, whereas IRS's P/E ratio is 3.59. In terms of profitability, HONIV's ROE is +0.36%, compared to IRS's ROE of +0.27%. Regarding short-term risk, HONIV is less volatile compared to IRS. This indicates potentially lower risk in terms of short-term price fluctuations for HONIV.Check IRS's competition here
HONIV vs SPLP Comparison April 2026
HONIV plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HONIV stands at 127.6B. In comparison, SPLP has a market cap of 955.2M. Regarding current trading prices, HONIV is priced at $200.99, while SPLP trades at $50.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HONIV currently has a P/E ratio of N/A, whereas SPLP's P/E ratio is 4.31. In terms of profitability, HONIV's ROE is +0.36%, compared to SPLP's ROE of +0.21%. Regarding short-term risk, HONIV is less volatile compared to SPLP. This indicates potentially lower risk in terms of short-term price fluctuations for HONIV.Check SPLP's competition here
HONIV vs CRESY Comparison April 2026
HONIV plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HONIV stands at 127.6B. In comparison, CRESY has a market cap of 792.6M. Regarding current trading prices, HONIV is priced at $200.99, while CRESY trades at $12.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HONIV currently has a P/E ratio of N/A, whereas CRESY's P/E ratio is 5.70. In terms of profitability, HONIV's ROE is +0.36%, compared to CRESY's ROE of +0.23%. Regarding short-term risk, HONIV is less volatile compared to CRESY. This indicates potentially lower risk in terms of short-term price fluctuations for HONIV.Check CRESY's competition here
HONIV vs MATW Comparison April 2026
HONIV plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HONIV stands at 127.6B. In comparison, MATW has a market cap of 783.4M. Regarding current trading prices, HONIV is priced at $200.99, while MATW trades at $25.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HONIV currently has a P/E ratio of N/A, whereas MATW's P/E ratio is 35.45. In terms of profitability, HONIV's ROE is +0.36%, compared to MATW's ROE of +0.05%. Regarding short-term risk, HONIV is less volatile compared to MATW. This indicates potentially lower risk in terms of short-term price fluctuations for HONIV.Check MATW's competition here
HONIV vs CODI-PA Comparison April 2026
HONIV plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HONIV stands at 127.6B. In comparison, CODI-PA has a market cap of 593.3M. Regarding current trading prices, HONIV is priced at $200.99, while CODI-PA trades at $18.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HONIV currently has a P/E ratio of N/A, whereas CODI-PA's P/E ratio is 21.35. In terms of profitability, HONIV's ROE is +0.36%, compared to CODI-PA's ROE of -0.40%. Regarding short-term risk, HONIV is less volatile compared to CODI-PA. This indicates potentially lower risk in terms of short-term price fluctuations for HONIV.Check CODI-PA's competition here
HONIV vs CODI-PB Comparison April 2026
HONIV plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HONIV stands at 127.6B. In comparison, CODI-PB has a market cap of 585.4M. Regarding current trading prices, HONIV is priced at $200.99, while CODI-PB trades at $19.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HONIV currently has a P/E ratio of N/A, whereas CODI-PB's P/E ratio is 23.14. In terms of profitability, HONIV's ROE is +0.36%, compared to CODI-PB's ROE of -0.40%. Regarding short-term risk, HONIV is less volatile compared to CODI-PB. This indicates potentially lower risk in terms of short-term price fluctuations for HONIV.Check CODI-PB's competition here
HONIV vs CODI Comparison April 2026
HONIV plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HONIV stands at 127.6B. In comparison, CODI has a market cap of 577.4M. Regarding current trading prices, HONIV is priced at $200.99, while CODI trades at $7.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HONIV currently has a P/E ratio of N/A, whereas CODI's P/E ratio is -2.11. In terms of profitability, HONIV's ROE is +0.36%, compared to CODI's ROE of -0.40%. Regarding short-term risk, HONIV is less volatile compared to CODI. This indicates potentially lower risk in terms of short-term price fluctuations for HONIV.Check CODI's competition here
HONIV vs FIP Comparison April 2026
HONIV plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HONIV stands at 127.6B. In comparison, FIP has a market cap of 556.6M. Regarding current trading prices, HONIV is priced at $200.99, while FIP trades at $4.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HONIV currently has a P/E ratio of N/A, whereas FIP's P/E ratio is -2.08. In terms of profitability, HONIV's ROE is +0.36%, compared to FIP's ROE of -0.13%. Regarding short-term risk, HONIV is less volatile compared to FIP. This indicates potentially lower risk in terms of short-term price fluctuations for HONIV.Check FIP's competition here
HONIV vs TRC Comparison April 2026
HONIV plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HONIV stands at 127.6B. In comparison, TRC has a market cap of 514.1M. Regarding current trading prices, HONIV is priced at $200.99, while TRC trades at $19.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HONIV currently has a P/E ratio of N/A, whereas TRC's P/E ratio is 173.55. In terms of profitability, HONIV's ROE is +0.36%, compared to TRC's ROE of +0.00%. Regarding short-term risk, HONIV is less volatile compared to TRC. This indicates potentially lower risk in terms of short-term price fluctuations for HONIV.Check TRC's competition here
HONIV vs FBYD Comparison April 2026
HONIV plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HONIV stands at 127.6B. In comparison, FBYD has a market cap of 445.9M. Regarding current trading prices, HONIV is priced at $200.99, while FBYD trades at $11.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HONIV currently has a P/E ratio of N/A, whereas FBYD's P/E ratio is -45.92. In terms of profitability, HONIV's ROE is +0.36%, compared to FBYD's ROE of -0.39%. Regarding short-term risk, HONIV is less volatile compared to FBYD. This indicates potentially lower risk in terms of short-term price fluctuations for HONIV.Check FBYD's competition here
HONIV vs SPLP-PA Comparison April 2026
HONIV plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HONIV stands at 127.6B. In comparison, SPLP-PA has a market cap of 369.8M. Regarding current trading prices, HONIV is priced at $200.99, while SPLP-PA trades at $23.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HONIV currently has a P/E ratio of N/A, whereas SPLP-PA's P/E ratio is 6.46. In terms of profitability, HONIV's ROE is +0.36%, compared to SPLP-PA's ROE of +0.21%. Regarding short-term risk, HONIV is less volatile compared to SPLP-PA. This indicates potentially lower risk in terms of short-term price fluctuations for HONIV.Check SPLP-PA's competition here
HONIV vs FIPWV Comparison April 2026
HONIV plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HONIV stands at 127.6B. In comparison, FIPWV has a market cap of 328.2M. Regarding current trading prices, HONIV is priced at $200.99, while FIPWV trades at $3.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HONIV currently has a P/E ratio of N/A, whereas FIPWV's P/E ratio is N/A. In terms of profitability, HONIV's ROE is +0.36%, compared to FIPWV's ROE of -0.40%. Regarding short-term risk, HONIV is less volatile compared to FIPWV. This indicates potentially lower risk in terms of short-term price fluctuations for HONIV.Check FIPWV's competition here
HONIV vs RCMT Comparison April 2026
HONIV plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HONIV stands at 127.6B. In comparison, RCMT has a market cap of 143.3M. Regarding current trading prices, HONIV is priced at $200.99, while RCMT trades at $19.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HONIV currently has a P/E ratio of N/A, whereas RCMT's P/E ratio is 11.31. In terms of profitability, HONIV's ROE is +0.36%, compared to RCMT's ROE of +0.36%. Regarding short-term risk, HONIV is less volatile compared to RCMT. This indicates potentially lower risk in terms of short-term price fluctuations for HONIV.Check RCMT's competition here
HONIV vs TUSK Comparison April 2026
HONIV plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HONIV stands at 127.6B. In comparison, TUSK has a market cap of 126.7M. Regarding current trading prices, HONIV is priced at $200.99, while TUSK trades at $2.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HONIV currently has a P/E ratio of N/A, whereas TUSK's P/E ratio is -1.98. In terms of profitability, HONIV's ROE is +0.36%, compared to TUSK's ROE of -0.30%. Regarding short-term risk, HONIV is less volatile compared to TUSK. This indicates potentially lower risk in terms of short-term price fluctuations for HONIV.Check TUSK's competition here
HONIV vs NNBR Comparison April 2026
HONIV plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HONIV stands at 127.6B. In comparison, NNBR has a market cap of 70.3M. Regarding current trading prices, HONIV is priced at $200.99, while NNBR trades at $1.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HONIV currently has a P/E ratio of N/A, whereas NNBR's P/E ratio is -1.31. In terms of profitability, HONIV's ROE is +0.36%, compared to NNBR's ROE of -0.26%. Regarding short-term risk, HONIV is less volatile compared to NNBR. This indicates potentially lower risk in terms of short-term price fluctuations for HONIV.Check NNBR's competition here
HONIV vs CRESW Comparison April 2026
HONIV plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HONIV stands at 127.6B. In comparison, CRESW has a market cap of 18.8M. Regarding current trading prices, HONIV is priced at $200.99, while CRESW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HONIV currently has a P/E ratio of N/A, whereas CRESW's P/E ratio is N/A. In terms of profitability, HONIV's ROE is +0.36%, compared to CRESW's ROE of +0.23%. Regarding short-term risk, HONIV is more volatile compared to CRESW. This indicates potentially higher risk in terms of short-term price fluctuations for HONIV.Check CRESW's competition here
HONIV vs EFSH Comparison April 2026
HONIV plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HONIV stands at 127.6B. In comparison, EFSH has a market cap of 1.9M. Regarding current trading prices, HONIV is priced at $200.99, while EFSH trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HONIV currently has a P/E ratio of N/A, whereas EFSH's P/E ratio is -0.00. In terms of profitability, HONIV's ROE is +0.36%, compared to EFSH's ROE of +0.45%. Regarding short-term risk, HONIV is less volatile compared to EFSH. This indicates potentially lower risk in terms of short-term price fluctuations for HONIV.Check EFSH's competition here
HONIV vs DOTAU Comparison April 2026
HONIV plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HONIV stands at 127.6B. In comparison, DOTAU has a market cap of 851. Regarding current trading prices, HONIV is priced at $200.99, while DOTAU trades at $10.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HONIV currently has a P/E ratio of N/A, whereas DOTAU's P/E ratio is N/A. In terms of profitability, HONIV's ROE is +0.36%, compared to DOTAU's ROE of +0.90%. Regarding short-term risk, HONIV is more volatile compared to DOTAU. This indicates potentially higher risk in terms of short-term price fluctuations for HONIV.Check DOTAU's competition here
HONIV vs ELECU Comparison April 2026
HONIV plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HONIV stands at 127.6B. In comparison, ELECU has a market cap of 0. Regarding current trading prices, HONIV is priced at $200.99, while ELECU trades at $10.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HONIV currently has a P/E ratio of N/A, whereas ELECU's P/E ratio is N/A. In terms of profitability, HONIV's ROE is +0.36%, compared to ELECU's ROE of N/A. Regarding short-term risk, HONIV is more volatile compared to ELECU. This indicates potentially higher risk in terms of short-term price fluctuations for HONIV.Check ELECU's competition here
HONIV vs STLRU Comparison April 2026
HONIV plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HONIV stands at 127.6B. In comparison, STLRU has a market cap of 0. Regarding current trading prices, HONIV is priced at $200.99, while STLRU trades at $10.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HONIV currently has a P/E ratio of N/A, whereas STLRU's P/E ratio is N/A. In terms of profitability, HONIV's ROE is +0.36%, compared to STLRU's ROE of N/A. Regarding short-term risk, HONIV is more volatile compared to STLRU. This indicates potentially higher risk in terms of short-term price fluctuations for HONIV.Check STLRU's competition here
HONIV vs JBK Comparison April 2026
HONIV plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HONIV stands at 127.6B. In comparison, JBK has a market cap of 0. Regarding current trading prices, HONIV is priced at $200.99, while JBK trades at $26.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HONIV currently has a P/E ratio of N/A, whereas JBK's P/E ratio is N/A. In terms of profitability, HONIV's ROE is +0.36%, compared to JBK's ROE of N/A. Regarding short-term risk, HONIV is more volatile compared to JBK. This indicates potentially higher risk in terms of short-term price fluctuations for HONIV.Check JBK's competition here
HONIV vs OBCI Comparison April 2026
HONIV plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HONIV stands at 127.6B. In comparison, OBCI has a market cap of 0. Regarding current trading prices, HONIV is priced at $200.99, while OBCI trades at $13.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HONIV currently has a P/E ratio of N/A, whereas OBCI's P/E ratio is 25.55. In terms of profitability, HONIV's ROE is +0.36%, compared to OBCI's ROE of +0.30%. Regarding short-term risk, HONIV is more volatile compared to OBCI. This indicates potentially higher risk in terms of short-term price fluctuations for HONIV.Check OBCI's competition here
HONIV vs FNTEU Comparison April 2026
HONIV plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HONIV stands at 127.6B. In comparison, FNTEU has a market cap of 0. Regarding current trading prices, HONIV is priced at $200.99, while FNTEU trades at $10.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HONIV currently has a P/E ratio of N/A, whereas FNTEU's P/E ratio is N/A. In terms of profitability, HONIV's ROE is +0.36%, compared to FNTEU's ROE of N/A. Regarding short-term risk, HONIV is more volatile compared to FNTEU. This indicates potentially higher risk in terms of short-term price fluctuations for HONIV.Check FNTEU's competition here